ArticleBreast cancer research and treatment2026
Real-world outcomes of reduced-dose versus standard-dose antibody drug conjugates in metastatic breast cancer: a retrospective cohort study.
Nickolas Stabellini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.